title: Drug-induced erythema nodosum after the administration of certolizumab in Crohn's disease.
authors: L
authors: L
authors: Biedermann
authors: K
authors: K
authors: Kerl
authors: G
authors: G
authors: Rogler
authors: G F L
authors: GF
authors: Hofbauer
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage* / Q000009:adverse effects*; D000068582:Certolizumab Pegol; D003424:Crohn Disease / Q000188:drug therapy*; D004893:Erythema Nodosum / Q000139:chemically induced* / Q000188:drug therapy; D005260:Female; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000008:administration & dosage* / Q000009:adverse effects*; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D008875:Middle Aged; D011092:Polyethylene Glycols / Q000008:administration & dosage* / Q000009:adverse effects*; D011379:Prognosis
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D007140:Immunoglobulin Fab Fragments; D007166:Immunosuppressive Agents; D011092:Polyethylene Glycols; D000068582:Certolizumab Pegol